Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis


Efe C., Al Taii H., Ytting H., Aehling N., Bhanji R. A. , Hagstrom H., ...Daha Fazla

DIGESTIVE DISEASES AND SCIENCES, cilt.63, ss.1348-1354, 2018 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 63 Konu: 5
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1007/s10620-018-5011-x
  • Dergi Adı: DIGESTIVE DISEASES AND SCIENCES
  • Sayfa Sayıları: ss.1348-1354

Özet

We studied the efficacy and safety of mycophenolate mofetil (MMF) and tacrolimus as second-line therapy in pediatric patients with autoimmune hepatitis (AIH) who were intolerant or non-responders to standard therapy (corticosteroid and azathioprine).